Ingram Micro New Zealand said it has reached a significant milestone in its partnership with Cure Kids, having raised more than NZ$520,000 for the charity since 2013.
This substantial contribution has supported crucial advancements in paediatric health research, positively impacting thousands of children across New Zealand.
Cure Kids, established in 1971, is a long running charity dedicated to funding research aimed at improving the lives of children with serious health conditions.
Over its 50-year history, the charity has invested more than NZ$65 million in New Zealand-based research, significantly shaping the diagnosis and treatment of seriously ill children.
During Ingram Micro's 11-year support, Cure Kids has achieved several breakthroughs in child health research.
These include proving that vitamin D supplementation during pregnancy and infancy reduces doctor visits for acute respiratory infections, developing a robotic gait trainer for children with cerebral palsy, and finding evidence that sleeping on one's side during pregnancy can halve the risk of stillbirths.
"Ingram Micro is honoured to contribute to the incredible advancements that Cure Kids has raised for paediatric research in New Zealand," Leon De Suza, managing director of Ingram Micro New Zealand said.
The chief executive of Cure Kids, Frances Soutter, said Ingram Micro was a long-term supporter of the charity, and expressed gratitude for their passion for what the organisation does and an unwavering commitment to fundraising events.
The technology distributor's most recent fundraising initiative was its Red Nose Day Event on 9 July.
Ingram Micro NZ plans to host the Ingram Micro Cure Kids Golf Day on 29 November and support the upcoming Cure Kids Gala on 9 August and Rebel Sport 24 Hour Team Challenge on 15-16 October.
More information on Cure Kids' initiatives and how to support them can be found at the charity's website.
-1.jpg&w=100&c=1&s=0)
.png&w=100&c=1&s=0)
